Post-COVID-19 Era: Infectious Diseases from One Health and Global Health Perspectives

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Medical Biology".

Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 6909

Special Issue Editors

Vanke School of Public Health, Tsinghua University, Beijing 100084, China
Interests: infectious diseases; vector-borne diseases; climate change; dengue; plague; mathematical statistical model
Special Issues, Collections and Topics in MDPI journals
Respiratory Medicine Unit, Department of Medicine & Centre for Molecular Medicine, Karolinska Institute, 171 77 Stockholm, Sweden
Interests: respiratory diseases; infectious diseases; bioinformatics; molecular medicine; global health

Special Issue Information

Dear Colleagues,

With the spread of the coronavirus disease 2019 (COVID-19) pandemic in the past few years, there has been an increasing concern about infectious diseases due to the ongoing adverse health effects of COVID-19 on the global population. This Special Issue aims to highlight empirical studies concerning the mechanisms of infectious diseases and outline the need for behavior and policy changes at all levels in the post-COVID-19 era.

This Special Issue will include reviews and research articles on the "Post-COVID-19 Era: Infectious Diseases from One Health and Global Health Perspectives". We are pleased to invite researchers to contribute to this Special Issue. Research areas may include (but are not limited to) the following: infectious diseases; COVID-19; One Health; global health; public health, ecosystems; modelling (e.g., structural equation modelling); and big data. Please send us an abstract before submission to ensure that your work falls within the scope of this Special Issue.

We look forward to receiving your contributions.

Dr. Lei Xu
Dr. Jing Gao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infectious diseases
  • COVID-19
  • One Health
  • structural equation model
  • ecosystems
  • big data

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1262 KiB  
Review
Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19
by Zahra Shabani, Jialing Liu and Hua Su
Biology 2023, 12(8), 1106; https://doi.org/10.3390/biology12081106 - 9 Aug 2023
Cited by 4 | Viewed by 6514
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and a member of the corona virus family, primarily affecting the upper respiratory system and the lungs. Like many other respiratory viruses, SARS-CoV-2 can spread to other organ systems. Apart from [...] Read more.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and a member of the corona virus family, primarily affecting the upper respiratory system and the lungs. Like many other respiratory viruses, SARS-CoV-2 can spread to other organ systems. Apart from causing diarrhea, another very common but debilitating complication caused by SARS-CoV-2 is neurological symptoms and cognitive difficulties, which occur in up to two thirds of hospitalized COVID-19 patients and range from shortness of concentration and overall declined cognitive speed to executive or memory function impairment. Neuro-cognitive dysfunction and “brain fog” are frequently present in COVID-19 cases, which can last several months after the infection, leading to disruption of daily life. Cumulative evidence suggests that SARS-CoV-2 affects vasculature in the extra-pulmonary systems directly or indirectly, leading to impairment of endothelial function and even multi-organ damage. The post COVID-19 long-lasting neurocognitive impairments have not been studied fully and their underlying mechanism remains elusive. In this review, we summarize the current understanding of the effects of COVID-19 on vascular dysfunction and how vascular dysfunction leads to cognitive impairment in patients. Full article
Show Figures

Figure 1

Back to TopTop